We are all looking for those small opportunities to improve the bottom line.

It is never easy, however with the support of Actavis it has been made easy.

Click here to view the analysis which clearly shows the additional margin you can make by continuing to purchase and dispensing this product until 31 March 2018 or stocks are exhausted.

If you have not converted from Ava 20 ED Tab 84 to Microgynon 20 E Tab 3×28 then you should seriously consider this exceptional offer. If you have then it may require you to reconsider.

This offer is available NOW and where practical we do seek your support to move this stock through the supply chain.

Thanking you in anticipation of your support.

About The Author